company background image
OGN logo

Organon NYSE:OGN Stock Report

Last Price

US$16.04

Market Cap

US$4.1b

7D

-11.2%

1Y

44.2%

Updated

10 Nov, 2024

Data

Company Financials +

OGN Stock Overview

Develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women’s health in the United States and internationally.

OGN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance4/6
Financial Health1/6
Dividends4/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Organon & Co. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Organon
Historical stock prices
Current Share PriceUS$16.04
52 Week HighUS$23.10
52 Week LowUS$10.84
Beta0.80
11 Month Change-10.89%
3 Month Change-17.57%
1 Year Change44.24%
33 Year Change-52.40%
5 Year Changen/a
Change since IPO-51.76%

Recent News & Updates

The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 04
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Recent updates

The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 04
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis

Sep 19

These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Sep 13
These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way

Organon & Co.: Cheap With Caveats

Aug 22

Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Aug 09
Organon (NYSE:OGN) Will Pay A Dividend Of $0.28

Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Aug 07
Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price

Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum

Jul 30

Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

May 29
Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year

Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

May 10
Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals

Four Reasons Why Organon Stock Is A Good Buy

May 07

Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Apr 21
Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings

Organon Stock Is Still Worth A Look

Feb 24

Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Feb 19
Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28

Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last

Feb 16

Organon: What I'm Looking For In This 8% Yield In 2024

Jan 03

High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued

Dec 19

Organon: It's Darkest Before The Dawn

Nov 30

Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace

Nov 07

Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Nov 05
Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28

Organon: The Federal Reserve Black Swan (Rating Upgrade)

Oct 04

6% Yield And Significantly Undervalued: A Closer Look At Organon

Sep 10

Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk

Aug 10

Organon & Co.: A Tough Spot To Be In Right Now

Jul 16

Organon goes ex-dividend tomorrow

Feb 23

Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 19
Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Is There Anything Organic Or Interesting About Organon?

Feb 07

Organon goes ex-dividend tomorrow

Nov 09

Organon's (NYSE:OGN) Dividend Will Be $0.28

Nov 08
Organon's (NYSE:OGN) Dividend Will Be $0.28

Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Nov 05
Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)

Shareholder Returns

OGNUS PharmaceuticalsUS Market
7D-11.2%-0.1%5.0%
1Y44.2%17.1%36.1%

Return vs Industry: OGN exceeded the US Pharmaceuticals industry which returned 17.1% over the past year.

Return vs Market: OGN exceeded the US Market which returned 36.1% over the past year.

Price Volatility

Is OGN's price volatile compared to industry and market?
OGN volatility
OGN Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement9.6%
Market Average Movement6.2%
10% most volatile stocks in US Market15.2%
10% least volatile stocks in US Market2.9%

Stable Share Price: OGN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: OGN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
202010,000Kevin Aliwww.organon.com

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women’s health in the United States and internationally. Its women’s health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage. The company’s biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; and two oncology products, including Ontruzant and Aybintio.

Organon & Co. Fundamentals Summary

How do Organon's earnings and revenue compare to its market cap?
OGN fundamental statistics
Market capUS$4.13b
Earnings (TTM)US$1.30b
Revenue (TTM)US$6.41b

3.2x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OGN income statement (TTM)
RevenueUS$6.41b
Cost of RevenueUS$2.68b
Gross ProfitUS$3.73b
Other ExpensesUS$2.43b
EarningsUS$1.30b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)5.05
Gross Margin58.26%
Net Profit Margin20.30%
Debt/Equity Ratio1,774.6%

How did OGN perform over the long term?

See historical performance and comparison

Dividends

7.0%

Current Dividend Yield

22%

Payout Ratio

Does OGN pay a reliable dividends?

See OGN dividend history and benchmarks
When do you need to buy OGN by to receive an upcoming dividend?
Organon dividend dates
Ex Dividend DateNov 12 2024
Dividend Pay DateDec 12 2024
Days until Ex dividend2 days
Days until Dividend pay date32 days

Does OGN pay a reliable dividends?

See OGN dividend history and benchmarks